DK1485057T3 - Derivater af azaspiroforbindelser til behandling af smerter - Google Patents
Derivater af azaspiroforbindelser til behandling af smerterInfo
- Publication number
- DK1485057T3 DK1485057T3 DK03711903T DK03711903T DK1485057T3 DK 1485057 T3 DK1485057 T3 DK 1485057T3 DK 03711903 T DK03711903 T DK 03711903T DK 03711903 T DK03711903 T DK 03711903T DK 1485057 T3 DK1485057 T3 DK 1485057T3
- Authority
- DK
- Denmark
- Prior art keywords
- treatment
- pain
- derivatives
- compounds
- azaspiro compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/423—Oxazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/424—Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10210195A DE10210195B4 (de) | 2002-03-07 | 2002-03-07 | Verwendung von 1,3-Diazaspiro-[4,5]decan-2,4-dithion zur Behandlung von Schmerz |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1485057T3 true DK1485057T3 (da) | 2006-05-08 |
Family
ID=27771113
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK03711903T DK1485057T3 (da) | 2002-03-07 | 2003-02-27 | Derivater af azaspiroforbindelser til behandling af smerter |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US7282515B2 (es) |
| EP (1) | EP1485057B9 (es) |
| AT (1) | ATE314043T1 (es) |
| AU (1) | AU2003218670A1 (es) |
| DE (2) | DE10210195B4 (es) |
| DK (1) | DK1485057T3 (es) |
| ES (1) | ES2254915T3 (es) |
| PL (1) | PL372432A1 (es) |
| WO (1) | WO2003073979A2 (es) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1261465C (zh) † | 2001-12-21 | 2006-06-28 | 阿克佐诺贝尔股份有限公司 | 氯乙烯单体聚合反应中在压降期间的有机引发剂的添加 |
| US8257680B1 (en) | 2004-02-24 | 2012-09-04 | The General Hospital Corporation | Catalytic radiofluorination |
| US9017724B2 (en) | 2004-02-24 | 2015-04-28 | The General Hospital Corporation | Catalytic radiofluorination |
| WO2009117728A2 (en) | 2008-03-21 | 2009-09-24 | The General Hospital Corporation | Compounds and compositions for the detection and treatment of alzheimer's disease and related disorders |
| DE102010063971A1 (de) * | 2010-12-22 | 2012-06-28 | Bayerische Motoren Werke Aktiengesellschaft | Verfahren und Vorrichtung zum Betreiben eines Energiespeichers |
| PL3402781T3 (pl) | 2016-01-13 | 2020-09-21 | Grünenthal GmbH | Pochodne 3-((hetero-)arylo)-8-amino-2-okso-1,3-diazaspiro-[4.5]-dekanu |
| DK3402785T3 (da) | 2016-01-13 | 2020-04-20 | Gruenenthal Gmbh | 3-(carboxymethyl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decan-derivater |
| CN108602777B (zh) | 2016-01-13 | 2022-05-03 | 格吕伦塔尔有限公司 | 3-((杂-)芳基)-烷基-8-氨基-2-氧代-1，3-氮杂-螺-[4.5]-癸烷衍生物 |
| SI3402783T1 (sl) | 2016-01-13 | 2020-10-30 | Gruenenthal Gmbh | Derivati 3-(karboksietil)-8-amino-2-okso-1,3-diaza-spiro-(4.5)-dekana |
| HUE051642T2 (hu) | 2016-01-13 | 2021-03-01 | Gruenenthal Gmbh | 8-amino-2-oxo-1,3-diaza-spiro-[4,5]-dekán származékok |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2716648A (en) | 1955-08-30 | Hydantoin derivatives | ||
| US2732380A (en) | 1956-01-24 | Process for the production of | ||
| US2866734A (en) * | 1956-12-05 | 1958-12-30 | Us Vitamin Corp | 3-pyridylethyl 2, 4-oxazolidinediones and process |
| US3150143A (en) | 1960-07-19 | 1964-09-22 | Geschicketer Fund For Medical | Therapeutically active nu-substituted azaspiranes |
| GB1015026A (en) * | 1961-04-04 | 1965-12-31 | Science Union & Cie | New derivatives of 2-oxazolidinone and the preparation thereof |
| GB995864A (en) * | 1962-02-10 | 1965-06-23 | Distillers Co Yeast Ltd | New derivatives of hydantoins |
| US3629276A (en) * | 1969-07-16 | 1971-12-21 | Abbott Lab | 2-amino-5-spiro-substituted-oxazo compounds |
| US4105774A (en) | 1975-07-28 | 1978-08-08 | The United States Of America As Represented By The Secretary Of State | Hydantoin compounds and methods of use thereof |
| US4147797A (en) | 1978-08-11 | 1979-04-03 | Pfizer Inc. | Spiro-furanohydantoin derivatives |
| US4181729A (en) | 1979-03-21 | 1980-01-01 | Pfizer Inc. | Phenyl or phenoxy substituted spiro-imidazolidinedione derivatives |
| US4235911A (en) | 1979-06-13 | 1980-11-25 | Pfizer Inc. | Hydantoin derivatives |
| US4283409A (en) | 1979-10-29 | 1981-08-11 | Pfizer Inc. | Imidazolone derivatives |
| US4430335A (en) | 1983-02-09 | 1984-02-07 | Hoechst-Roussel Pharmaceuticals Inc. | Substituted 1-azaspiro[4,5]decanes and their analgesic compositions |
| GB8612630D0 (en) | 1986-05-23 | 1986-07-02 | Ici Plc | Biocides |
| WO1993012786A1 (en) | 1986-07-10 | 1993-07-08 | Howard Harry R Jr | Indolinone derivatives |
| WO1993013092A1 (en) | 1986-11-24 | 1993-07-08 | Reinhard Sarges | Imidazolidinedione derivatives |
| MX12896A (es) | 1987-09-04 | 1993-06-01 | Pfizer | Procedimiento para preparar un compuesto de espiro-heteroazolonas |
| GB8916447D0 (en) | 1989-07-19 | 1989-09-06 | Ici Plc | Composition,process and use |
| US5319135A (en) | 1989-08-25 | 1994-06-07 | Warner-Lambert Company | Process for cyclic amino acid anticonvulsant compounds |
| US5132451A (en) | 1989-08-25 | 1992-07-21 | Warner-Lambert Company | Process for cyclic amino acid anticonvulsant compounds |
| US5852029A (en) | 1990-04-10 | 1998-12-22 | Israel Institute For Biological Research | Aza spiro compounds acting on the cholinergic system with muscarinic agonist activity |
| US5534520A (en) | 1990-04-10 | 1996-07-09 | Fisher; Abraham | Spiro compounds containing five-membered rings |
| GB9326432D0 (en) * | 1993-12-24 | 1994-02-23 | Oxford Asymmetry Ltd | Improvements in or relating to chiral anxiliaries |
| US5925672A (en) * | 1996-12-06 | 1999-07-20 | Neurosciences Research Foundation, Inc. | Methods of treating mental diseases, inflammation and pain |
| DE19732928C2 (de) | 1997-07-31 | 2000-05-18 | Gruenenthal Gmbh | Verwendung substituierter Imidazolidin-2,4-dion-Verbindungen als Schmerzmittel |
| US5948807A (en) | 1997-09-03 | 1999-09-07 | Regents Of The University Of Minnesota | Spiroindanamines and Spiroindanimides |
| DE19751062A1 (de) | 1997-11-18 | 1999-07-08 | Univ Ludwigs Albert | An 4-Stellung substituierte 2-Pyrrolidinon-Derivate zur Verringerung des extrazellulären Glutamat-Spiegels |
| GB9805172D0 (en) * | 1998-03-11 | 1998-05-06 | Zeneca Ltd | Composition and use |
| EP1082306A1 (en) | 1998-05-26 | 2001-03-14 | Warner-Lambert Company | Conformationally constrained amino acid compounds having affinity for the alpha2delta subunit of a calcium channel |
-
2002
- 2002-03-07 DE DE10210195A patent/DE10210195B4/de not_active Expired - Fee Related
-
2003
- 2003-02-27 ES ES03711903T patent/ES2254915T3/es not_active Expired - Lifetime
- 2003-02-27 DK DK03711903T patent/DK1485057T3/da active
- 2003-02-27 WO PCT/EP2003/001985 patent/WO2003073979A2/de not_active Application Discontinuation
- 2003-02-27 AU AU2003218670A patent/AU2003218670A1/en not_active Abandoned
- 2003-02-27 EP EP03711903A patent/EP1485057B9/de not_active Expired - Lifetime
- 2003-02-27 AT AT03711903T patent/ATE314043T1/de not_active IP Right Cessation
- 2003-02-27 PL PL03372432A patent/PL372432A1/xx not_active Application Discontinuation
- 2003-02-27 DE DE50302062T patent/DE50302062D1/de not_active Expired - Fee Related
-
2004
- 2004-09-07 US US10/935,794 patent/US7282515B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DE10210195B4 (de) | 2005-12-15 |
| EP1485057B1 (de) | 2005-12-28 |
| PL372432A1 (en) | 2005-07-25 |
| WO2003073979A2 (de) | 2003-09-12 |
| ES2254915T3 (es) | 2006-06-16 |
| WO2003073979A3 (de) | 2003-12-31 |
| AU2003218670A1 (en) | 2003-09-16 |
| DE10210195A1 (de) | 2004-01-22 |
| US7282515B2 (en) | 2007-10-16 |
| ATE314043T1 (de) | 2006-01-15 |
| EP1485057A2 (de) | 2004-12-15 |
| EP1485057B9 (de) | 2006-06-28 |
| AU2003218670A8 (en) | 2003-09-16 |
| DE50302062D1 (de) | 2006-02-02 |
| US20050119319A1 (en) | 2005-06-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1095749A1 (en) | Novel use of peptide compounds for in production of pharmacenticals for treating central neuropathic pain | |
| ZA200406813B (en) | Glytaminyl based DPIV inhibitors | |
| NO20030895D0 (no) | Ny anvendelse av dipeptidyl peptidase IV inhibitorer | |
| TW200407305A (en) | Novel compounds | |
| MXPA04008772A (es) | Composiciones de clorhidrato de naltrexona. | |
| HK1092467A1 (en) | N-alkyl-hydroxamic acid-isoindolyl compounds and their pharmaceutical uses n- | |
| TW200510301A (en) | Novel compounds | |
| TW200510325A (en) | 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof | |
| PL1682530T3 (pl) | Podstawione pirolo-indole jako inhibitory PAI-1 | |
| DE60323749D1 (de) | Substituierte pyrroline als kinase inhibitoren | |
| WO2007002361A3 (en) | 3-fluoro-piperidine t-type calcium channel antagonists | |
| TW200700064A (en) | Novel compounds | |
| TW200700071A (en) | Novel use | |
| MY141528A (en) | Anilinopyrazole derivatives useful for the treatment of diabetes | |
| DK1485057T3 (da) | Derivater af azaspiroforbindelser til behandling af smerter | |
| WO2004021988A3 (en) | Treatment of pain by inhibition of p38 map kinase | |
| TW200504402A (en) | Antimicrobial lenses, processes to prepare them and methods of their use | |
| EA200400438A1 (ru) | Применение ирбесартана для изготовления лекарств, которые пригодны для предупреждения или лечения лёгочной гипертонии | |
| MXPA04004090A (es) | Compuestos substituidos de 1h-quinolin-2-ona. | |
| DE10342670A1 (de) | Isoliertes Photoprotein mtClytin, sowie dessen Verwendung | |
| MXPA06000700A (es) | Compuestos de sulfonildihidroimidazopiridinona como ligandos de 5-hidroxitriptamina-6. | |
| UA87117C2 (ru) | Применение пептидных соединений для лечения центральной невропатической боли | |
| RS20050429A (en) | Combination medicament | |
| MXPA04001205A (es) | Compuesto para eliminar y/o mitigar la anhedonia. | |
| UA85187C2 (en) | 2-aminobenzoyl derivatives |